Skip to content

Polyphasic Sleep in Sleep Apnoea Patients

Polyphasic Sleep in Sleep Apnoea Patients - Polyphas_OSA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00012549
Enrollment
50
Registered
2017-06-09
Start date
2016-03-22
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G47

Interventions

Group 1: This is a single arm study without control group in patients with established polyphasic sleep. Polysomnographic recording is done in addition to the nighttime sleep also for the daytime slee

Sponsors

Fachkrankenhaus Kloster Grafschaft GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: established polyphasic sleep behaviour in the majority of the weekdays with daytime sleep phases in addition to the nighttime sleep

Exclusion criteria

Exclusion criteria: monophasic sleep pattern, shift work, sleep-wake rhythm disorder, insomnia, neurological diseases, thyroid hormones imbalance

Design outcomes

Primary

MeasureTime frame
The aim of this study is the complete polysomnographic recording of night- and daytime sleep phases during diagnostic investigations in patients admitted for the first time to the sleep laboratory with the suspect of having sleep apnoea. This is a prerequisite for the comparison of quantitative sleep parameters between nighttime and daytime sleep and for the severity of a possible wrong assessment of sleep quality when only the the nighttime sleep is taken into account as it is done in sleep laboratory standard routine.

Secondary

MeasureTime frame
Scoring of quantitative sleep Parameters in 50 patients with established polyphasic sleep behaviour

Countries

Germany

Contacts

Public ContactJens Kerl

Fachkrankenhaus Kloster Grafschaft GmbH

j.kerl@fkkg.de02972-7911703

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026